Huge Progress in Personalized Medicine for Breast Cancer - But Evidence/Translation Gaps Remain
{"Image DocumentName": "Huge Progress in Personalized Medicine for Breast Cancer - But Evidence/Translation Gaps Remain", "Image ImageDescription": "Many genetically different breast cancers & tx are toxic, ineffective, & expensive. ~30% of women with breast cancer are HER+ & can benefit from Herceptin. Gene expression profiling (OncotypeDx, Mammaprint) assesses who will benefit from chemo. Gaps\u2026\u2026as used in actual practice. Lack of evidence\u2026.so that it is most effective & least costly.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}